Chronic cough, a persistent and debilitating condition, poses diagnostic and therapeutic challenges to clinicians due to its multifactorial nature.
It's imperative to identify the underlying cause, which often includes gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma. A detailed history and physical examination, supplemented by targeted investigations, can elucidate the root cause.
Treatment should be tailored according to the identified cause. Empirical therapy for the most common causes can be an effective initial approach. In refractory cases, a stepwise evaluation may be necessary.
Patients should be educated about the chronic nature of the condition, the need for follow-up, and the importance of adherence to therapy.
In conclusion, a comprehensive approach to diagnosing and managing chronic cough can improve patient outcomes and reduce healthcare utilization.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation